A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon (Pancrelipase) With an Alternate Source of Active Pharmaceutical Ingredient
Latest Information Update: 26 Jul 2024
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- Sponsors AbbVie
- 14 Sep 2023 Status changed from active, no longer recruiting to completed.
- 26 Jun 2023 Planned End Date changed from 15 Nov 2023 to 4 Sep 2023.
- 21 Apr 2023 Planned primary completion date changed from 10 Oct 2023 to 7 Jul 2023.